Skip to main content
Gland Pharma Limited (NSE:GLAND)
India flag India · Delayed Price · Currency is INR
1,403.70
-9.60 (-0.68%)
May 7, 2025, 3:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Generic Injectibles
56.65B
Log In
Log In
Log In
Log In
Generic Injectibles Growth
56.29%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
United States
26.88B
Log In
Log In
Log In
Log In
United States Growth
28.54%
Log In
Log In
Log In
Log In
Rest of World
11.82B
Log In
Log In
Log In
Log In
Rest of World Growth
71.43%
Log In
Log In
Log In
Log In
Europe
10.53B
Log In
Log In
Log In
Log In
Europe Growth
462.62%
Log In
Log In
Log In
Log In
India
5.88B
Log In
Log In
Log In
Log In
India Growth
5.97%
Log In
Log In
Log In
Log In
Canada
890.27M
Log In
Log In
Log In
Log In
Canada Growth
12.00%
Log In
Log In
Log In
Log In
Australia
626.45M
Log In
Log In
Log In
Log In
Australia Growth
187.05%
Log In
Log In
Log In
Log In
New Zealand
28.17M
Log In
Log In
Log In
Log In
New Zealand Growth
159.39%
Log In
Log In
Log In
Log In